Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EIS-GO steroid response prediction study in active Graves' orbitopathy
NL-OMON51784Not yet recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylprednisolone in Graves' ophthalmopathy (TED), sponsored by Het Oogziekenhuis Rotterdam. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on NL-OMON51784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51784.